CTSA pilot studies awarded to three pharmaceutical sciences faculty members

CTSA Lab.

Published April 29, 2016 This content is archived.

Supported by a combination of funds from the Clinical and Translational Science Award (CTSA) and institutional support, the CTSA has awarded 7 teams of researchers pilot studies to support innovative clinical and translational research projects. Two of the teams feature faculty from the Department of Pharmaceutical Sciences.

Awardees:
Donald Mager, associate professor, pharmaceutical sciences, Wen Wee Ma and Robert Straubinger, professor, pharmaceutical sciences


Title of Project:
Pharmacological Network Analysis and Modeling of Complex Chemotherapeutic Regimens in Pancreatic Cancer: Pharmacodynamic Design of Novel Combination Therapies

Awardees:
Jun Qu, associate professor, pharmaceutical sciences, John Canty and Jianmin Wang


Title of Project:
Novel Circulating Biomarkers for Sudden Cardiac Death

A rigorous two-tired review process identified the meritorious proposals guided by the following criteria:

  • Scientific merit and innovation
  • Significance and impact on the field
  • Potential for securing extramural funding

Based on criteria in the Request for Proposals, reviewers also placed special emphasis on studies that:

  • addressed healthcare disparities or underrepresented populations in Western New York
  • developed novel methodologies and technologies toward generalizable solutions to translational research problems
  • included a mentoring component by pairing a promising junior investigator with an established funded investigator